Budget, vaccines, judicial ethics: 6 key MD laws going into effect July 1
Here are some key Maryland policies that take effect July 1, from the new budget to vaccinations to contraception.
Trump says FDA Commissioner Marty Makary is out
FDA Commissioner Marty Makary resigned, President Donald Trump said, after weeks of clashing with top White House and health advisers.
Moore signs vaccine, housing legislation after Sine Die
Maryland Gov. Wes Moore signed a series of bills into law Tuesday, just hours after the Maryland General Assembly adjourned its annual legislative session.
Choose life, protect childhood immunizations
Commentary: Health Secretary RFK Jr., offers disease, disability, and death—all in the name of junk science. Vaccines offer life.
Where do Gov. Wes Moore’s 2026 bills stand?
Gov. Wes Moore brought five bills before the Maryland General Assembly for the 2026 session. Where has his legislation landed?
Judge upends RFK overhaul of childhood vaccine policies
A federal judge blocked key parts of Health Secretary Robert F. Kennedy Jr.'s effort to reshape U.S. vaccine policy.
MD-based Novavax raises 2026 outlook on strength in vaccine deals
Gaithersburg-based Novavax raised its adjusted revenue forecast for 2026, as it expects milestone payments from vaccine supply and licensing deals to offset sagging demand.
Kennedy ally Casey Means edges closer to surgeon general job
Wellness influencer Casey Means, a key ally of Health Secretary Robert F. Kennedy Jr., advanced toward confirmation as U.S. surgeon general.
MD, states suing Trump administration over vaccine policy changes
Democrat-led states, including Maryland, are suing the Trump administration over recent changes to the federal government's childhood vaccine schedule.
Maryland approves $164M surge funding for hospitals
Gov. Wes Moore announced $164 million in surge funding to help Maryland hospitals manage rising flu, RSV and COVID-19 cases statewide.
MD-based Novavax signs agreement with Pfizer for vaccine development
Maryland-based Novavax signed a licensing agreement allowing Pfizer access to its technology that boosts immune responses to vaccines.
Former MD CEO charged with insider trading tied to COVID vaccine contamination
An ex-executive of Gaithersburg-based Emergent BioSolutions was charged with selling stock while knowing about problems at a Baltimore plant.
















